{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:12:37Z","timestamp":1788599557073,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.adro.2026.102156","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:25:43Z","timestamp":1785338743000},"page":"102156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dose-Escalated Radiation Therapy for Muscle-Invasive Bladder Cancer: A Retrospective Analysis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3310-2091","authenticated-orcid":false,"given":"Li","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anzela","family":"Anzela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viet","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Roncolato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Descallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Stanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sved","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sidhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102156_bib0001","unstructured":"Cancer Australia. Bladder cancer statistics in Australia. Accessed November 1, 2025. https:\/\/www.canceraustralia.gov.au\/cancer-types\/bladder-cancer\/bladder-cancer-statistics-australia"},{"key":"10.1016\/j.adro.2026.102156_bib0002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: A systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0003","doi-asserted-by":"crossref","first-page":"866","DOI":"10.6004\/jnccn.2022.0041","article-title":"NCCN Guidelines\u00ae insights: Bladder cancer, version 2.2022","volume":"20","author":"Flaig","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.adro.2026.102156_bib0004","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2025.02.019","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2025 guidelines","volume":"87","author":"van der Heijden","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0005","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/1754-9485.13120","article-title":"FROGG patterns of practice survey and consensus recommendations on radiation therapy for MIBC","volume":"64","author":"Cardoso","year":"2020","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102156_bib0006","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JU.0000000000003981","article-title":"Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; Amended 2020, 2024)","volume":"212","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0007","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eururo.2025.03.017","article-title":"Bladder preservation strategies in muscle-invasive bladder cancer: Recommendations from the international bladder cancer group","volume":"89","author":"Gupta","year":"2026","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2022.05.009","article-title":"Paving the road to the future of chemoradiotherapy in muscle-invasive bladder cancer: 10-year follow-up of BC2001","volume":"82","author":"Solanki","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1672431","article-title":"Management of bladder cancer recurrence following the trimodality therapy","volume":"15","author":"Damaj","year":"2025","journal-title":"Front Oncol"},{"issue":"suppl 4","key":"10.1016\/j.adro.2026.102156_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1464-410X.2012.11476.x","article-title":"Management of local recurrences in the irradiated bladder: A systematic review","volume":"110","author":"Sapre","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2026.102156_bib0011","doi-asserted-by":"crossref","first-page":"e421","DOI":"10.1016\/j.clon.2022.05.003","article-title":"Mapping local failure following bladder radiotherapy according to dose","volume":"34","author":"Abdel-Aty","year":"2022","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.adro.2026.102156_bib0012","doi-asserted-by":"crossref","first-page":"6424","DOI":"10.18632\/oncotarget.7024","article-title":"Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence","volume":"7","author":"Parodi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2026.102156_bib0013","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0090-4295(01)01219-5","article-title":"Selective bladder conservation using transurethral resection, chemotherapy, and radiation: Management and consequences of Ta, T1, and Tis recurrence within the retained bladder","volume":"58","author":"Zietman","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.adro.2026.102156_bib0014","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijrobp.2015.09.010","article-title":"Clinical outcomes with dose-escalated adaptive radiation therapy for urinary bladder cancer: A prospective study","volume":"94","author":"Murthy","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102156_bib0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2024.09.006","article-title":"Dose-escalated adaptive radiotherapy for bladder cancer: Results of the Phase 2 RAIDER randomised controlled trial","volume":"87","author":"Huddart","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0016","article-title":"Dose-escalated radiation therapy as primary treatment for residual bladder cancer after transurethral resection","volume":"9","author":"Chang","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102156_bib0017","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1002\/cncr.30719","article-title":"Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy","volume":"123","author":"Korpics","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2026.102156_bib0018","unstructured":"National Cancer Institute. CTCAE and adverse event reporting. June 25, 2025. Accessed October 17, 2025. https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events"},{"key":"10.1016\/j.adro.2026.102156_bib0019","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-8140(98)00089-9","article-title":"Muscle-invasive bladder cancer treated with external beam radiotherapy: Pretreatment prognostic factors and the predictive value of cystoscopic re-evaluation during treatment","volume":"49","author":"Moonen","year":"1998","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102156_bib0020","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00345-020-03436-0","article-title":"Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: A systematic review and meta-analysis","volume":"39","author":"Schuettfort","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.adro.2026.102156_bib0021","unstructured":"Springer Nature Link. Diagnosis of micrometastasis in muscle invasive bladder cancer through immunohistochemistry analysis: Is there indication for routine evaluation? Applied Cancer Research. Accessed May 15, 2026. https:\/\/link.springer.com\/article\/10.1186\/s41241-016-0005-5"},{"key":"10.1016\/j.adro.2026.102156_bib0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/diagnostics10010039","article-title":"Biomarkers for bladder cancer diagnosis and surveillance: A comprehensive review","volume":"10","author":"Batista","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.adro.2026.102156_bib0023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/biomed4030017","article-title":"Assessing lymph node involvement in muscle-invasive bladder cancer: Proposal of a predictive model using clinical variables","volume":"4","author":"Barrag\u00e1n Flores","year":"2024","journal-title":"BioMed"},{"key":"10.1016\/j.adro.2026.102156_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222223","article-title":"Prognostic value of preoperative hydronephrosis in patients with bladder cancer undergoing radical cystectomy: A meta-analysis","volume":"14","author":"Zhu","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.adro.2026.102156_bib0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102156_bib0026","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1470-2045(20)30607-0","article-title":"Hypofractionated radiotherapy in locally advanced bladder cancer: An individual patient data meta-analysis of the BC2001 and BCON trials","volume":"22","author":"Choudhury","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102156_bib0027","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2015.12.379","article-title":"Prospective study delivering simultaneous integrated high-dose tumor boost (\u226470 Gy) with image guided adaptive radiation therapy for radical treatment of localized muscle-invasive bladder cancer","volume":"94","author":"Hafeez","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102156_bib0028","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMoa2511674","article-title":"Perioperative enfortumab vedotin and pembrolizumab in bladder cancer","volume":"394","author":"Vulsteke","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.adro.2026.102156_bib0029","doi-asserted-by":"crossref","first-page":"TPS913","DOI":"10.1200\/JCO.2026.44.7_suppl.TPS913","article-title":"SWOG 2427: Single arm phase II study of bladder preservation with immunoradiotherapy after a clinically meaningful response to neoadjuvant therapy in patients with muscle invasive bladder cancer (BRIGHT)","volume":"44","author":"Ballas","year":"2026","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102156_bib0030","series-title":"The phase III adaptive radiation and chemotherapy for muscle invasive bladder cancer trial (ARCHER)","year":"2026"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426001636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:36:27Z","timestamp":1788597387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426001636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2452109426001636"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102156","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-Escalated Radiation Therapy for Muscle-Invasive Bladder Cancer: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102156","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102156"}}